Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer
Dzana Dervovic, Ahmad Malik, Edward L. Y. Chen, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22

Showing 22 citing articles:

Exploring treatment options in cancer: Tumor treatment strategies
Beilei Liu, Hongyu Zhou, Licheng Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 155
CRISPR–Cas9 applications in T cells and adoptive T cell therapies
Xiaoying Chen, Shuhan Zhong, Yonghao Zhan, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 13
CRISPR/Cas9 technology for advancements in cancer immunotherapy: from uncovering regulatory mechanisms to therapeutic applications
Xiaohang Feng, Z Y Li, Yuping Liu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Finding a needle in a haystack: functional screening for novel targets in cancer immunology and immunotherapies
Yi Du, Yang Yang, Bohao Zheng, et al.
Oncogene (2025)
Open Access | Times Cited: 1
Functional genomics identifies N-acetyllactosamine extension of complex N-glycans as a mechanism to evade lysis by natural killer cells
Xiaoxuan Zhuang, James S. Woods, Yanlong Ji, et al.
Cell Reports (2024) Vol. 43, Iss. 4, pp. 114105-114105
Open Access | Times Cited: 5
Preclinical Models of Solid Cancers for Testing Cancer Immunotherapies
F. Navarro Expósito, Kelli A. Connolly, Tang Tang, et al.
Annual Review of Cancer Biology (2025) Vol. 9, Iss. 1, pp. 285-305
Closed Access
CRISPR/Cas9 screening: unraveling cancer immunotherapy’s ‘Rosetta Stone’
Baoxiang Chen, Yanrong Deng, Xianghai Ren, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 8, pp. 736-749
Open Access | Times Cited: 4
CRISPRing KRAS: A Winding Road with a Bright Future in Basic and Translational Cancer Research
Xian Gong, Jianting Du, Ren‐Wang Peng, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 460-460
Open Access | Times Cited: 2
Tumor microenvironment RNA test to predict immunotherapy outcomes in advanced gastric cancer: The TIMES001 trial
Min Shi, Dongqiang Zeng, Hui Luo, et al.
Med (2024) Vol. 5, Iss. 11, pp. 1378-1392.e3
Closed Access | Times Cited: 2
Advances in CRISPR Based Biosensing Strategies for Cancer Diagnosis
Qi-Ling Yang, Xinyi Zhong, Linmin Zhong, et al.
Cancer Screening and Prevention (2024) Vol. 3, Iss. 1, pp. 56-66
Open Access | Times Cited: 1
Testis Specific Serine Kinase 6 (TSSK6) is abnormally expressed in colorectal cancer and promotes oncogenic behaviors
Magdalena Delgado, Zachary R. Gallegos, Steve Stippec, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 6, pp. 107380-107380
Open Access | Times Cited: 1
The biological function of Serpinb9 and Serpinb9-based therapy
Haozhe Huang, Yiqing Mu, Song Li
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
High-throughput screening for optimizing adoptive T cell therapies
Yuchen Zhang, Qinglong Xu, Zhifei Gao, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Impact of disulfidptosis-associated clusters on breast cancer survival rates and guiding personalized treatment
Xiong Chen, Guo‐Huang Hu, Qianle Yu
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 2
Unveiling immune checkpoint regulation: exploring the power of in vivo CRISPR screenings in cancer immunotherapy
Yuxiang Wang, Athar Khalil, Amina Kamar, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 2
Testis Specific Serine Kinase 6 (TSSK6) is abnormally expressed in colorectal cancer and promotes oncogenic behaviors
Magdalena Delgado, Zachary R. Gallegos, Steve Stippec, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
TMBcalc: a computational pipeline for identifying pan-cancer Tumor Mutational Burden gene signatures
Grete Francesca Privitera, Salvatore Alaimo, Anna Caruso, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access
EML4-ALK variant-specific genetic interactions shape lung tumorigenesis
Alberto Diaz-Jimenez, Emily G. Shuldiner, Kálmán Somogyi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
CRISPR screening meets spatial omics: Opportunities and challenges
Yinxing Ma
Elsevier eBooks (2024)
Closed Access
Serpin B9 is Highly Expressed in Lung Adenocarcinoma and is Associated with Progression-Free Survival
Yue Fang, Yi Yue, Shuang Hao, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 8881-8890
Open Access
Applications of CRISPR technology
Zhiyan Du
Elsevier eBooks (2024), pp. 23-74
Closed Access
Applications of CRISPR screening to lung cancer treatment
Wanying Shen, Fangli Hu, Lei Pan, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 1
Tumor immune evasion: insights from CRISPR screens and future directions
Tirta M. Djajawi, Johannes Wichmann, Stephin J. Vervoort, et al.
FEBS Journal (2023) Vol. 291, Iss. 7, pp. 1386-1399
Open Access
Page 1

Scroll to top